Of course Mr. Magical couldn't be wrong! He sold ahead of earnings at 1.2 and bought back on earnings day at 1.09!
Sarcasm aside, while FFS can have some intriguing charts, usually when I see his posts claiming something extraordinary, FFS stands for something other than FlyFishingStocks
All of THAT said, Amarin does appear set up for an interesting move. If the AHA data is good enough, it is plausible that it reignites ROW hopes because it seems that Reduce-It acceptance has been a major impediment in growing worldwide. If there wasn't a reluctance to accept it (the European initial approval process appeared to allude to a reluctance which is why I brought it up), then that means that management is actively torpedoing negotiations themselves, which is a very worrying thought.
The above is a lot of "ifs" though. Pure speculation on a lot of things going just right is not a rock solid investing strategy